title: Lanthanides enhance pulmonary absorption of insulin.
abstract: In an effort to investigate the enhancement effect of lanthanide ions (Ln3+) on the absorption of larger molecules from the pulmonary pathway, insulin (mol. wt. = 5730) was chosen as a model peptide. The absorption of insulin preadministered or coadministered with Ln3+ from the lung was investigated by means of an in situ pulmonary absorption experiment. The enhancement absorption of insulin by Ln3+ ions was evaluated by calculating the various bioavailabilities (Fr) of insulin from pulmonary absorption. Moreover, the temporal change of Gd content in serum was also investigated. Results showed that the promoting effect of Ln3+ on the bioavailability of insulin is closely related to its species, concentration, and delivery order. The effect of the median Ln3+ series was remarkably greater than that of light and heavy Ln3+. The anionic form of Gadolinium (Fr = 68.4%) seemed to be more effective compared with its cationic form (Fr = 59.5%). Coadministration of Gd3+ with insulin (Fr = 80.1%) was the most effective in increasing insulin absorption from the lung. Gd3+ was rapidly absorbed and metabolized to a normal level after 4 h. It was suggested that lanthanides in a very low concentration might become potent absorption enhancers to improve absorption of larger molecules via the pulmonary pathway.
authors.affiliation: Department of Pharmacy, Beijing Medical University, People's Republic of China.
authors.forename: Z C
authors.initials: ZC
authors.lastname: Shen
authors.forename: Y
authors.initials: Y
authors.lastname: Cheng
authors.forename: Q
authors.initials: Q
authors.lastname: Zhang
authors.forename: S L
authors.initials: SL
authors.lastname: Wei
authors.forename: R C
authors.initials: RC
authors.lastname: Li
authors.forename: K
authors.initials: K
authors.lastname: Wang
mesh_terms: D000042:Absorption; D000280:Administration, Inhalation; D000818:Animals; D001682:Biological Availability; D005682:Gadolinium / Q000097:blood / Q000378:metabolism; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D007328:Insulin / Q000008:administration & dosage / Q000493:pharmacokinetics*; D008168:Lung / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D008674:Metals, Rare Earth / Q000097:blood / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D012996:Solutions
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin; D008674:Metals, Rare Earth; D012996:Solutions; D005682:Gadolinium